Matsuura H, Nakazawa S
Gan To Kagaku Ryoho. 1984 Apr;11(4):912-6.
FT-207 suppository was administered to 19 patients with brain tumors. FT-207 and 5-FU concentrations in tumor tissues and plasma were measured using chemical assay method. After operation, FT-207 and 5-FU concentrations in plasma and CSF were measured serially for 24 hours in some patients following administration of FT-207 suppository. Following results were obtained. 1) The level of 5-FU concentration in tumor tissues was higher than that of in plasma while the level of FT-207 concentration in tumor tissues was lower than that of in plasma. 2) The level of 5-FU concentration in CSF had been kept highly very longer time, compared with that of in plasma. On the other hand the level of FT-207 concentration in plasma and CSF decreased rapidly. 3) About 0,05 mcg/ml of 5-FU in CSF would be maintained for 24 hours in patients following administration of FT-207 suppository (1 g, daily) for 3 days or more.
对19例脑肿瘤患者给予FT - 207栓剂。采用化学分析法测定肿瘤组织和血浆中FT - 207和5 - FU的浓度。术后,部分患者在给予FT - 207栓剂后连续24小时测定血浆和脑脊液中FT - 207和5 - FU的浓度。获得以下结果。1)肿瘤组织中5 - FU的浓度水平高于血浆中的浓度水平,而肿瘤组织中FT - 207的浓度水平低于血浆中的浓度水平。2)与血浆相比,脑脊液中5 - FU的浓度水平在很长时间内一直保持较高。另一方面,血浆和脑脊液中FT - 207的浓度迅速下降。3)在给予FT - 207栓剂(1 g,每日)3天或更长时间的患者中,脑脊液中约0.05 mcg/ml的5 - FU可维持24小时。